{"id":"W3129328931","doi":"10.1111/jgh.15463","title":"Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease","year":2021,"lang":"en","type":"article","venue":"Journal of Gastroenterology and Hepatology","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eisai Canada; EA Pharma Co., Ltd.","keywords":"Medicine; Internal medicine; Crohn's disease; Gastroenterology; Adverse effect; Anemia; Pharmacokinetics; Antibody; Pharmacodynamics; Immunology; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001171239,0.0008002034,0.001463227,0.0002737567,0.0002468626,0.0004827193,0.000355857,0.0008886462,0.001902415],"category_scores_gemma":[0.0008508575,0.0003388,0.0006070611,0.000170651,0.0004353586,0.00040976,0.000183946,0.001569296,0.0004273664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003786422,"about_ca_system_score_gemma":0.000746814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002435475,"about_ca_topic_score_gemma":0.0005620685,"domain_scores_codex":[0.9996793,0.0001561242,0.00001618304,0.00005380823,0.00004102753,0.00005357218],"domain_scores_gemma":[0.9993482,0.0001444103,0.0001558803,0.00005884037,0.00006553446,0.0002272284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6231409,0.07632519,0.01657351,0.00102389,0.0009882866,0.0006838034,0.0003188216,0.002552875,0.1231639,0.0002258896,0.003438211,0.1515647],"study_design_scores_gemma":[0.192183,0.7709453,0.02351708,0.00002922499,0.0002496705,0.0007623169,0.00003266741,0.0009479997,0.008111877,0.00009768232,0.003104625,0.00001863175],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957845,0.001562275,0.000447197,0.0001492334,0.00004874922,0.0008147776,0.0003978357,0.00004418779,0.0007511289],"genre_scores_gemma":[0.9942119,0.0008183409,0.001120568,0.0005208094,0.0001060317,0.0008188584,0.000979295,0.00001081856,0.001413455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001902415,"threshold_uncertainty_score":0.006364167,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01021376224106261,"score_gpt":0.2840211022022823,"score_spread":0.2738073399612197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}